InspireMD (NSPR) has issued an announcement.
InspireMD, Inc. has successfully exercised Series H warrants, resulting in the issuance of common and pre-funded warrants and generating $17.9 million in gross proceeds. This financial boost, primarily intended to further develop their CGuard Prime and SwitchGuard medical systems, signals a confident expansion of the company’s innovative healthcare solutions, offering an attractive narrative for investors in the biomedical sector.
For detailed information about NSPR stock, go to TipRanks’ Stock Analysis page.
